Second Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium: A Case-Based Approach

Second Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium: A Case-Based Approach is organized by Scripps Health and will be held on Sep 21, 2019 at San Diego Marriott Del Mar, San Diego, California, United States of America.

Target Audience:
• Cardiologists
• Oncologists
• Internists
• Nurse Practitioners
• Physician Assistants

Accreditation:
Scripps Health designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 6.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Physician Assistants:
PAs may claim a maximum of 6.5 Category 1 credits for completing this activity. 

Description
The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to cardiomyopathy and cardiovascular health of cancer survivors. Cardio-oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular toxicities. Similarly cardiac amyloidosis is a burgeoning disease with exciting new treatments. The program is intended for those involved in the care of patients with cardiomyopathies, diastolic heart failure, chemotherapy or radiation induced heart disease, pulmonary hypertension, and cardiomyopathy related arrhythmic diseases.

Nationally recognized faculty will cover challenging heart failure topics related to common cardiomyopathies, role of hemodynamic testing, latest structural heart therapies, ventricular assist devices and transplantation, cardio-oncology, cardiac imaging, electrophysiology, and genomics. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.

Educational Objectives
After attending this live activity, participants should be able to:
• Assess the risks of oncologic treatment-related cardiac dysfunction for patients who have undergone therapy for cancer.
• Implement strategies for early detection, correction of cardiac risk factors, and close and long-term cardiac monitoring in order to reduce the effects of cardiotoxicity for patients who are at risk of cancer treatment-related cardiac dysfunction, including heart failure, valvular dysfunction and autonomic dysfunction.
• Recognize potential cardiovascular complications of novel molecular targeted therapies, including arrhythmias, cardiomyopathy, cardiac ischemia, and hypertension.
• Critically evaluate multi-modality imaging such as cardiac magnetic resonance (MR), echocardiography, and nuclear imaging including positron emission tomography (PET) scanning in the diagnosis and follow-up of cardiomyopathy.
• Describe patient selection for advanced diagnostics for dyspnea.
• Identify common clinical and diagnostic criteria that would prompt a detailed pulmonary hypertension evaluation.
• Apply recommendations from the recently updated ACC/AHA/Heart Failure Society of America (HFSA) guidelines when diagnosing and managing patients with cardiomyopathy.
• Discuss the latest diagnosis and treatment options available for cardiac amyloidosis.
• Incorporate guidelines and algorithms for the evaluation and management of patients with syncope, sudden cardiac death, and cardiac sarcoidosis based on current recommendations from the ACC/AHA/Heart Rhythm Society (HRS).
• Evaluate available clinical evidence for recommendations for the management of cardiovascular disease during pregnancy.
• Identify patients who would benefit from implantable pulmonary artery sensor monitoring.
• Illustrate the importance of the multidisciplinary cardio-oncology team.

Time: 7:00 am - 4:00 pm